ARCOMA
ARCOMA has been active since 1988 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €61k and a net result of €2k. Equity is shrinking by ~6.9% per year across the filed fiscal years. Its solvency ranks better than 94% of 19339 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.2% (very low).
| Equity | €61k |
| Net result | €2k |
| Better than sector | 94% |
| Active | 37 yrs |
Strong profile, led by solvency.
All 5 axes are computed from data Checked has read.
How do we compute this?
The trend is a robust median of all pairwise slopes between fiscal years (Theil-Sen), so a single odd year cannot hijack the line. For strictly positive series we also fit a log variant (compound annual growth) and keep whichever describes the figures best.
The area around the projection is 1.8 × the median absolute deviation from the trend, widening each year ahead (×1 / ×1.6 / ×2.2), with a minimum of 8% of the last value. It is an indicative range, not a statistical confidence interval.
A series whose deviations exceed 35% of its level is too volatile: we then deliberately show no projection. Every projection assumes unchanged policy and is blind to non-public information (order book, contracts, funding rounds).
| Metric | This company | Sector median | Position in the sector |
|---|---|---|---|
| Solvency | 94.8% | 31.1% | |
| Net result | €2k | €4k | |
| Equity | €61k | €87k | |
| Gross operating margin | €-4k | €39k | |
| Total assets | €65k | €440k |
Figures by fiscal year and ratios
| Fiscal year | 2024 Δ | 2023 Δ | 2022 Δ | 2021 Δ |
|---|---|---|---|---|
| Deposit | micro schema | micro schema | micro schema | micro schema |
| Revenue | - | - | - | - |
| EBITDA | +19.0% | - | -83.3% | - |
| Net profit | - | -960.9% | - | - |
| Cash flow | - | - | -83.8% | - |
| Staff costs | - | - | - | - |
| Income taxes | - | - | - | - |
| Dividends | - | - | - | - |
| Total assets | -16.6% | -13.1% | -6.8% | - |
| Equity | +2.9% | -17.1% | -1.6% | - |
| Debt | -81.4% | +3.2% | -23.4% | - |
| of which ≤ 1y | -81.4% | +3.2% | -23.4% | - |
| of which > 1y | - | - | - | - |
| Working capital | +17.2% | -20.9% | +13.2% | - |
| Employees (FTE) | - | - | - | - |
| 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|
| Current ratio | 10.57 | 2.52 | 2.98 | 2.34 |
| Quick ratio | 10.57 | 2.52 | 2.98 | 2.34 |
| Working capital ratio | 49.4% | 35.1% | 38.5% | 31.7% |
| Solvency | 94.8% | 76.9% | 80.5% | 76.3% |
| Debt / equity | 0.05 | 0.30 | 0.24 | 0.31 |
| Long-term debt ratio | - | - | - | - |
| Interest coverage | -218.12 | -40.63 | 27.47 | 195.52 |
| Gross margin | - | - | - | - |
| Net margin | - | - | - | - |
| ROA | 2.6% | -15.8% | -1.3% | 18.7% |
| ROE | 2.8% | -20.6% | -1.6% | 24.5% |
| EBITDA margin | - | - | - | - |
| Days sales outstanding | - | - | - | - |
| Days payable outstanding | - | - | - | - |
| Inventory turnover | - | - | - | - |
| Days inventory (DSI) | - | - | - | - |
Full annual accounts (22 line items)
| Line item | Code | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Balance sheet, Assets | |||||
| TOTAL ASSETS | 20/58 | €65k | €77k | €89k | €96k |
| Fixed assets | 21/28 | €29k | €32k | €37k | €43k |
| Tangible fixed assets | 22/27 | €29k | €32k | €37k | €43k |
| Current assets | 29/58 | €35k | €45k | €52k | €53k |
| Amounts receivable within one year | 40/41 | €12k | €12k | €13k | €21k |
| Cash & bank | 54/58 | €23k | €32k | €38k | €32k |
| Balance sheet, Equity & liabilities | |||||
| TOTAL EQUITY & LIABILITIES | 10/49 | €65k | €77k | €89k | €96k |
| Equity | 10/15 | €61k | €59k | €72k | €73k |
| Contributions / capital | 10/11 | €6k | €6k | €6k | €6k |
| Reserves | 13 | €53k | €53k | €65k | €66k |
| Accumulated profits (losses) | 14 | €2k | €18 | €180 | €336 |
| Amounts payable | 17/49 | €3k | €18k | €17k | €23k |
| Amounts payable within one year | 42/48 | €3k | €18k | €17k | €23k |
| Trade debts payable within one year | 44 | €1k | €14k | €13k | €12k |
| Income statement | |||||
| Gross operating margin | 9900 | €-4k | €-5k | €6k | €26k |
| Operating result | 9901 | €-10k | €-12k | €-1k | €18k |
| Financial income | 75 | €1 | - | - | €15 |
| Financial charges | 65 | €26 | €172 | €151 | €127 |
| Result before taxes | 9903 | €2k | €-12k | €-1k | €18k |
| Income taxes | 67/77 | - | - | - | €12 |
| Net result for the period | 9904 | €2k | €-12k | €-1k | €18k |
| Result to be appropriated | 9905 | €2k | €-12k | €-1k | €18k |
| NACE primary | Real estate agency activities(68310) |
| Legal form | Private limited company(610) |
| Incorporation | 22-11-1988 |
| Status | Active |
| Postal code | 9000 |
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 44816K0915/00L004 | Flanders | 269 m² | 1 · 83 m² | 13.1 m · 3 fl. |
We know of 7 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
| Legal nameNL | ARCOMA |